|
|
Volumn 5, Issue 6, 2006, Pages 445-
|
|
First generic biologics finally approved
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BIOLOGICAL PRODUCT;
BLOOD CLOTTING FACTOR;
GENERIC DRUG;
GRANULOCYTE COLONY STIMULATING FACTOR;
HUMAN GROWTH HORMONE;
INSULIN;
MONOCLONAL ANTIBODY;
PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
UNCLASSIFIED DRUG;
VACCINE;
VALTROPIN;
GROWTH HORMONE;
ANTIBODY PRODUCTION;
ANTIBODY RESPONSE;
BIOEQUIVALENCE;
BIOTECHNOLOGY;
CLINICAL STUDY;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
IMMUNOGENICITY;
NONHUMAN;
NOTE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PURE RED CELL ANEMIA;
QUALITY CONTROL;
TREATMENT DURATION;
ARTICLE;
EUROPE;
BIOLOGICAL PRODUCTS;
DRUGS, GENERIC;
EUROPE;
GROWTH HORMONE;
|
|
EID: 33745650655
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2072 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|